Nicholas B. Lydon

Nicholas B.
Lydon was the founder of AnaptysBio, Inc. (founded in 2005) where he served as Director from 2005 to 2010.
He was also the founder of Kinetix Pharmaceuticals, Inc. (founded in 1997) where he held the title of President & Chief Executive Officer from 1997 to 2000.
In addition, he is the founder of Blueprint Medicines Corp.
(founded in 2008) where he currently serves as an Independent Director.
He is also the founder of Granite Biopharma LLC (founded in 2003) where he is a Member.
Furthermore, he founded Recludix Pharma, Inc. (founded in 2019) and served as Chairman from 2019 to 2022.
Dr. Lydon is also the founder of IDRx, Inc...
Dr. Lydon's current job is as a Managing Member at Staurus Pharma LLC since 2011.
His former positions include being a Director at Ambit Biosciences Corp.
from 2004 to 2009, Vice President-Small Molecule Drug Discovery at Amgen, Inc. from 2000 to 2002, and a Principal at Schering-Plough Corp.
He also worked as a Principal at Ciba-Geigy AG from 1985 to 1996.
Dr. Lydon's education includes an undergraduate degree from the University of Leeds and a doctorate degree from the University Of Dundee.